Status:
COMPLETED
Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Lead Sponsor:
Oticon Medical
Conditions:
Hearing Loss, Conductive
Hearing Loss Mixed
Eligibility:
All Genders
18+ years
Brief Summary
The study is part of the Post Market Clinical Follow (PMCF) activity. The investigational device is the CE-marked Ponto 3 SuperPower (available on the market since December 2016) already fitted to the...
Eligibility Criteria
Inclusion
- Subjects who have consented to Section 3 of the document: "GDPR - what this means to you" (Appendix A) as part of a clinical routine visit.
- Fitted unilaterally or bilaterally with the Ponto 3 SuperPower(s) on abutment(s)
- Adult subjects (18 years or older)
- Patient has attended a clinical routine visit where fitting of Ponto 3 SuperPower has been performed and at least one following clinical routine visit where audiological measurements has been performed
Exclusion
- There are no exclusion criteria in this study due to the retrospective nature of the study.
- \-
Key Trial Info
Start Date :
March 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 8 2021
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04803279
Start Date
March 16 2021
End Date
June 8 2021
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich, Norfolk, United Kingdom, NR4 7UY